USE OF BIOMARKERS TO EVALUATE THE EFFICACY OF A COMPOSITION IN REDUCING THE EFFECTS OF CANCER THERAPEUTICS ON SKIN

A method to evaluate the potential of cancer therapeutics to produce skin related side effects is disclosed. The method, which involves use of biological markers, can also be used to evaluate the efficacy of a composition in reducing the effects of cancer therapeutics on skin. L'invention conce...

Full description

Saved in:
Bibliographic Details
Main Authors ONDET, Thomas, STAMATAS, Georgios N, ROUX, Pierre-Francois, MONSHOUWER, Mario
Format Patent
LanguageEnglish
French
Published 24.06.2021
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PHYSICS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
TESTING
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:A method to evaluate the potential of cancer therapeutics to produce skin related side effects is disclosed. The method, which involves use of biological markers, can also be used to evaluate the efficacy of a composition in reducing the effects of cancer therapeutics on skin. L'invention concerne un procédé d'évaluation du potentiel d'agents thérapeutiques anticancéreux pour produire des effets secondaires liés à la peau. Le procédé, qui implique l'utilisation de marqueurs biologiques, peut également être utilisé pour évaluer l'efficacité d'une composition dans la réduction des effets d'agents thérapeutiques anticancéreux sur la peau.
Bibliography:Application Number: WO2020IB60233